Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults - T705US316

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02026349
Recruitment Status : Completed
First Posted : January 3, 2014
Last Update Posted : November 11, 2015
MediVector, Inc.
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 2015
Actual Study Completion Date : March 2015
Certification/Extension First Submitted : October 20, 2015